Smart Nanoparticles Undergo Phase Transition for Enhanced Cellular Uptake and Subsequent Intracellular Drug Release in a Tumor Microenvironment-Reference-Cited by-同舟云学术

Smart Nanoparticles Undergo Phase Transition for Enhanced Cellular Uptake and Subsequent Intracellular Drug Release in a Tumor Microenvironment

Published:2017-12-29 Issue:1 Volume:10 Page:278-289
ISSN:1944-8244
Container-title:ACS Applied Materials & Interfaces
language:en
Short-container-title:ACS Appl. Mater. Interfaces

Author:

Ye Guihua¹,Jiang Yajun¹,Yang Xiaoying¹,Hu Hongxiang²,Wang Beibei¹,Sun Lu¹,Yang Victor C.¹²^ORCID,Sun Duxin²,Gao Wei¹²^ORCID

Affiliation:

1. Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics), School of Pharmacy, Tianjin Medical University, Tianjin 300070, PR China

2. College of Pharmacy, University of Michigan, 428 Church Street, Ann Arbor, Michigan 48108, United States

Funder

Natural Science Foundation of Tianjin City

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Subject

General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsami.7b15978

Reference39 articles.

1. Doxil® — The first FDA-approved nano-drug: Lessons learned

2. Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL®/CAELYX®) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma

3. Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancer

4. Phase II trial of doxil for patients with metastatic melanoma refractory to frontline therapy.

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Timescale dependent homogeneous assembly of lipid-polymer hybrid nanoparticles in laminar mixing for enhanced lung cancer treatment;Chemical Engineering Journal;2024-10

2. Concomitant Delivery of Pirarubicin and Salinomycin Synergistically Enhanced the Efficacy of Cancer Therapy and Reduced the Risk of Cancer Relapse;AAPS PharmSciTech;2024-09-07

3. WITHDRAWN: Folic acid Grafted, cell-penetrating peptide conjugated pH-sensitive hydrophobically modified Glycol chitosan nanoparticles for drug delivery in breast cancer;Chemical Engineering Journal;2024-07

4. Applications of Biomolecular Nanostructures for Anti-Angiogenic Theranostics;International Journal of Nanomedicine;2024-06

5. Folate-Modified pH and ROS Dual-Responsive Polymeric Nanocarriers for Targeted Anticancer Drug Delivery;ACS Applied Nano Materials;2024-03-28